TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive “Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes November 1, 1974
TCL Archive In Brief: Phil Web, Former NCI Contracts Official, Dies; Minimal Breast Cancer Workshop Set February 15, 1980
TCL Archive Eight Practicing Physicians On Board are Enough, Need Some Scientists Now, DeVita Says December 9, 1983
TCL Archive Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial July 25, 2014
